cyclin D2 Antibodies

Santa Cruz Biotechnology delivers a wide array of cyclin D2 monoclonal antibodies for research in cell cycle regulation and cancer biology. Cyclin D2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclin D2 is a crucial regulatory protein that plays a significant role in the progression of the cell cycle, particularly in the transition from the G1 phase to the S phase. Its dysregulation is often associated with various cancers, making cyclin D2 a key target for understanding tumorigenesis and developing therapeutic strategies. By studying cyclin D2, researchers can gain insights into cellular proliferation and the mechanisms underlying cancer development. Understanding cyclin D2's function is essential for developing new therapeutic approaches in cancer treatment. Cyclin D2 research continues to reveal new aspects of cell cycle regulation and its impact on various biological processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of cyclin D2's role in cellular processes and disease mechanisms.